Thrombosis risk stratification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 8: | Line 8: | ||
Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor. | Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor. | ||
==Risk | ==Risk Factors== | ||
* | *General | ||
**Older age | **Older age | ||
**Female gender | **Female gender | ||
| Line 17: | Line 17: | ||
**Immobilization | **Immobilization | ||
* | *Medical | ||
**Surgery | **Surgery | ||
**[[Congestive heart failure and thrombosis|Heart failure]] | **[[Congestive heart failure and thrombosis|Heart failure]] | ||
| Line 31: | Line 31: | ||
**[[Disseminated intravascular coagulation]] | **[[Disseminated intravascular coagulation]] | ||
* | *Familial | ||
**[[Antithrombin|Antithrombin III deficiency]] | **[[Antithrombin|Antithrombin III deficiency]] | ||
**[[Protein C deficiency]]/[[Protein S deficiency]] | **[[Protein C deficiency]]/[[Protein S deficiency]] | ||
| Line 38: | Line 38: | ||
**Hypoplasminogenemia | **Hypoplasminogenemia | ||
**Familial homocysteinemia | **Familial homocysteinemia | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 15:33, 27 February 2013
|
Thrombosis Microchapters |
|
Site of Thrombosis |
|---|
|
Differentiating Thrombosis from other Diseases |
|
Diagnosis |
|
Treatment |
|
Thrombosis risk stratification On the Web |
|
Risk calculators and risk factors for Thrombosis risk stratification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]
Overview
Presence of a risk factor for thrombosis has an impact on the treatment of the patient. Short term anti-coagulation can be successful in the presence of a transient risk factor. Long term anti-coagulation is required in case of a persistent risk factor.
Risk Factors
- Medical
- Familial
- Antithrombin III deficiency
- Protein C deficiency/Protein S deficiency
- APC resistance (Factor V Leiden)
- Dysfibrogenemia
- Hypoplasminogenemia
- Familial homocysteinemia